Figures computed from official regulatory filings — .
Ownershipinsiders 22.39% · institutions 0%
In USD · as of Oct 5, 2026
Ask the machine
Search and compare insider transactions, companies and their statistics in plain language. Your question becomes a query over available data, not a conversation or investment advice.
Data for AXIM BIOTECHNOLOGIES, INC. only. No web search. Global per-insider statistics are excluded.
An executed search uses one credit, even with no results. Errors and unsupported questions use no credits.
AXIM Biotechnologies, Inc. develops diagnostic healthcare solutions for ophthalmological conditions. It develops and commercializes two point-of-care diagnostic tests to assist eye-care physicians in detecting and quantifying biomarkers associated with aqueous deficient dry eye disease and non-specific allergic conjunctivitis, including ocular total immunoglobulin E allergy test and lactoferrin ADDE test. It also operates a full-service center for custom biomarker and biopharmaceutical research, custom assay development, clinical sample testing, and precision data delivery. In addition, the company develops a line of novel diagnostics for early cancer detection, response to treatment, and recurrence monitoring, as well as COVID-19 rapid diagnostic tools. The company was formerly known as Axim International Inc. and changed its name to AXIM Biotechnologies, Inc. in July 2014. AXIM Biotechnologies, Inc. was incorporated in 2010 and is based in San Diego, California.
Market information source · Oct 5, 2026
Periods recorded in the consulted sources. These do not certify the legal dates of name changes.
SEC company identity · Oct 5, 2026
Open-market timeline · full history
3 buys2 sells— close pricebar = usd volume, √ scaleclick a period to filter the table
| Insider | Type | Value · USD | Signals | Details |
|---|---|---|---|---|
| Valencia Catalina | Buy | n/a (No price was disclosed in the filing) | conv 39 |
| SEC |
| Schroeder Blake | AwardD (derivative) | $1.2B | Unusual size | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | $62.5B | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | $62.5B | SEC |
| Valencia Catalina | AwardD (derivative) | $1.2T | SEC |
| MALASEK ROBERT | AwardD (derivative) | $2.9B | Unusual size | SEC |
| O'Rourke Peter | AwardD (derivative) | $1.2B | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | $250K | SEC |
| Scott Timothy Richard | AwardD (derivative) | $1.2B | Unusual size | SEC |
| Scott Timothy Richard | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cunningham Robert L | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MALASEK ROBERT | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Cunningham Robert L | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HUEMOELLER JOHN WALTER II | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Scott Timothy Richard | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Schroeder Blake | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| MALASEK ROBERT | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| HUEMOELLER JOHN WALTER II | Buy | n/a (No price was disclosed in the filing) | conv 96First in 12mo | SEC |
| HUEMOELLER JOHN WALTER II | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |
| Valencia Catalina | Buy | $115.8K | conv 27First in 12mo | SEC |
| Schroeder Blake | Other | $25.6K | SEC |
| Schroeder Blake | OtherD (derivative) | $625M | SEC |
| MALASEK ROBERT | Award | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC |